Valproic acid elimination rate and urinary excretion of its glucuronide conjugate in patients with epilepsy

Biological and Pharmaceutical Bulletin

Volumn 22, Issue 7, 1999, Pages 716-720

  Yoshida, Hisahiro ^a   Hirozane, Kiyoshi ^a   Kimoto, Hiroo ^a   Hayashi, Takasi ^b   Akiyama, Tatsuo ^b   Katayama, Hirokazu ^c   Watanabe, Miki ^c   Yoshitomi, Hironori ^c   Kamiya, Akira ^a  

^a YAMAGUCHI UNIVERSITY HOSPITAL   (Japan)

^b YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c FUKUYAMA UNIVERSITY   (Japan)

Author keywords

Epileptic patient; Glucuronide; Kidney; Metabolism; Urinary excretion; Valproic acid

Indexed keywords

VALPROIC ACID; VALPROIC ACID DERIVATIVE;

ADOLESCENT; ADULT; ARTICLE; CASE REPORT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG ELIMINATION; DRUG GLUCURONIDATION; DRUG MEGADOSE; DRUG URINE LEVEL; EPILEPSY; EXPERIMENTAL MODEL; HUMAN; MOLECULAR DYNAMICS; ORAL DRUG ADMINISTRATION; SUSTAINED RELEASE PREPARATION;

EID: 0032779276     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.22.716     Document Type: Article

References (20)

1. Asconape J. J., Penry J. K., Epilepsia, 23 (Suppl. 1), S65-79 (1982).
2. Tatsuhara T., Muro H., Jpn. J. Hosp. Pharm., 18, 329-342 (1990).
3. Loscher W., Epilepsia, 22, 169-178 (1981).
4. Gugler R., Schell A., Eichelbaum M., Frescher W., Schulz., Eur. J. Clin. Pharmacol., 12, 125-132 (1977).
5. Bruni J., Albright P. S., Clin. Neuropharmacol., 7, 1-34 (1984).
6. Gugler R., von Unruh G. E., Clin. Pharmacokinet., 5, 67-83 (1980).
7. Klotz U., Rapp T., Muller W. A., Eur. J. Clin. Pharmacol., 13, 55-60 (1978).
8. Kimoto H., Fujita T., Ishimoto K., Kamiya A., Jpn. J. TDM, 10, 109-110 (1993).
9. Kimoto H., Ishimoto K., Yoshida H., Kamiya A., Ichiyama T., Hayashi T., Jpn. J. Clin. Pharmacol. Ther., 26, 195-196 (1995).
10. Katayama H., Watanabe M., Yoshitomi H., Yoshida H., Kimoto H., Kamiya A., Hayashi T., Akimura T., Biol. Pharm. Bull., 21, 304-307 (1998).
11. Tatsuhara T., Muro H., Matsuda Y., Imai Y., J. Chromatogr., 399, 183-195 (1987).
12. Yoshida H., Kimoto H., Kamiya A., Katayama H., Yoshitomi H., Jpn. J. TDM, 15, 232-236 (1998).
13. Hori R., Okumura K., Kitazawa S., Koshiro A., Saitoh Y., Higuchi S., Mizugaki M., Yamaji A., Rikihisa T., Tanigawara Y., Yakuzaigaku, 49, 148-156 (1989).
14. Hori R., Okumura K., Kitazawa S., Koshiro A., Saitoh Y., Higuchi S., Mizugaki M., Yamaji A., Rikihisa T., Tanigawara Y., Yakuzaigaku, 50, 292-299 (1990).
15. Bowdle T. A., Patel I. H., Levy R. H., Wilensky A. J., Clin. Pharmacol. Ther., 28, 486-492 (1980).
16. Butler T. C., Fed. Proc., Fed. Am. Soc. Exp. Biol., 17, 1158-1162 (1958).
17. Brodie B. B., Hogben C. A., J. Pharm. Pharmacol., 9, 345-380 (1957).
18. Takeuchi A., Masuda T., Saitoh H., Hashimoto Y., Inui K., Xeno. Metab. Disp., 13 (Suppl), 176 (1998).
19. Yamamura N., Imura K., Naganuma H., Xeno. Metab. Disp., 13 (Suppl), 159 (1998).
20. Chu X., Kato Y., Niinuma K., Sudo K., Hakusui H., Sugiyama Y., J. Pharmacol. Exp. Ther., 281, 304-314 (1997).